NANOTETRAC TARGETS THE THYROID HORMONE RECEPTOR ON INTEGRIN v 3 TO PROMOTE APOPTOSIS, DISRUPT CELL DEFENSE PATHWAYS AND BLOCK ANGIOGENESIS Paul J.
